| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000030846 |
| Receipt No. | R000035216 |
| Official scientific title of the study | Nutrition-related factors associated with waiting list mortality in patients with interstitial lung disease |
| Date of disclosure of the study information | 2018/01/17 |
| Last modified on | 2018/01/17 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Nutrition-related factors associated with waiting list mortality in patients with interstitial lung disease | |
| Title of the study (Brief title) | Factors associated with waitlist mortality | |
| Region |
|
|
| Condition | ||||
| Condition | interstitial lung disease
chronic respiratory disease |
|||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | To find nutrition-related markers with waiting list mortality |
| Basic objectives2 | Others |
| Basic objectives -Others | association with wait list mortality and body compositions, serum albumin and serum transthyretin |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | to assess the relationship of nutrition-related factors with waiting list mortality |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. interstitial lung disease
|
|||
| Key exclusion criteria | 1. severe comorbidities
2. lung transplantation from living donors during hospitalization before registration to JOTN 3. hospitalization for a second lung transplantation 4. registration at another hospital 5. failure to meet the JOTN criteria 6. severe mental disorders 7. alcoholism 8. smoking 9. incomplete data |
|||
| Target sample size | 75 | |||
| Research contact person | |
| Name of lead principal investigator | Shinichi Harashima |
| Organization | Kyoto University |
| Division name | Diabetes, Endocrinology and Nutrition |
| Address | 54 Shogoin Kawahara-cho Sakyo-ku Kyoto |
| TEL | 0757513560 |
| harasima@kuhp.kyoto-u.ac.jp | |
| Public contact | |
| Name of contact person | Toyofumi F. Chen-Yoshikawa |
| Organization | Kyoto University |
| Division name | Thoracic Surgery |
| Address | 54 Shogoin Kawahara-cho Sakyo-ku Kyoto |
| TEL | 0757514975 |
| Homepage URL | |
| fengshic@kuhp.kyoto-u.ac.jp | |
| Sponsor | |
| Institute | Kyoto University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kyoto University Grant |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Seventy-six patients were screened; among them, 48 fulfilled the inclusion criteria.
The final analysis target was 40. Median observational period was 497 (range 97-1015) days; median survival time was 550 (95% CI 414-686) days. Mortality rate was 38.7/100 person-years. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035216 |